Updated Jul 16, 2026
Tousignant Jennifer is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $71K.
Jennifer Tousignant is the Chief Legal Officer of Viridian Therapeutics, Inc. (VRDN), a clinical-stage biopharmaceutical company focused on therapies for thyroid eye disease. In Viridian’s most recent SEC filing dated January 2, 2026, she is listed as Chief Legal Officer with no reported stock purchases or sales.
| Role | Insider |
|---|---|
| Notability | 42/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-09 | VRDN | Viridian Therapeutics, Inc.\DE | F — Tax withholding / forfeiture | 1.7K | $30.19 | $51K |
| 2026-03-05 | VRDN | Viridian Therapeutics, Inc.\DE | F — Tax withholding / forfeiture | 1.7K | $29.32 | $51K |
| 2026-03-05 | VRDN | Viridian Therapeutics, Inc.\DE | M — Option exercise | 5.2K | — | |
| 2026-01-02 | VRDN | Viridian Therapeutics, Inc.\DE | S — Open-market sale | 2.3K | $31.16 | $71K |
Jennifer Tousignant is the Chief Legal Officer of Viridian Therapeutics, Inc. (VRDN), a clinical-stage biopharmaceutical company focused on therapies for thyroid eye disease. In Viridian’s most recent SEC filing dated January 2, 2026, she is listed as Chief Legal Officer with no reported stock purchases or sales.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($71K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tousignant Jennifer profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.